openPR Logo
Press release

Genome Editing Market Thriving Revenue of US$ 10,691.0 million by 2025 with Leading Vendors: Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., GenScript, Horizon Discovery Group plc, Sangamo Therapeutics, Inc.

06-11-2021 08:10 AM CET | Health & Medicine

Press release from: The Insight Partners

Genome Editing Market

Genome Editing Market

The global genome editing market is expected to reach US$ 10,691.0 million by 2025 from US$ 3,210.1 million in 2017; it is estimated to grow at a CAGR of 17.0% from 2018 to 2027.

Genome editing is a technique that is utilized for the changes that are to be done in the DNA of a cell or an organism. The technique involves cutting DNA sequences for the addition or removing of the DNA in the genome. The changes in the genome are done for the required characteristics of the cell. Genome editing is done for the research purpose, the treatment of diseases, and the biotechnological purpose. Factors such as an Increase in funding for genome editing, rising prevalence of genetic disorders, rise in the advancements for genome editing technology and rise in the production of genetically modified crops are the driving factors for the growth of the market. However, the growth of the market is restrained by various factors such as the perception of the people for genetic alteration and stringent regulation.

The market for genome editing is expected to grow in the coming near future due to the growth factor that is driving the market is the increase in funding. The different government in the different regions are increasing their funds and grants to develop genome editing research. Owing to genome editing's advantages, the various government is supporting their public and private research and academic institutes for increasing the research activities for the genome editing and genetic engineering.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

To Know How COVID-19 Pandemic Will Impact Global Genome Editing Market | Get a Sample Copy of Report, Click Here:
https://www.theinsightpartners.com/sample/TIPHE100000853/?source=openpr-10411

Top key vendors:
• Transposagen Biopharmaceuticals, Inc.
• Integrated DNA Technologies, Inc.
• Thermo Fisher Scientific Inc.
• GenScript
• Lonza
• Horizon Discovery Group plc
• Sangamo Therapeutics, Inc.
• New England Biolabs
• Editas Medicine
• Merck KGaA.

Global Genome Editing Market – By Technology
• TALENS
• CRISPR
• ZFNs
• Others

Global Genome Editing Market– By Application
• Genetic Engineering
• Cell Line Engineering
• Others

Global Genome Editing Market– By End User
• Biotechnology & Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic & Government Research Institutes

North America, Latin America, Asia-Pacific, Africa, and Europe have been examined on the basis of different leading key players. The business profiles of several top-level companies have been profiled to get informative data for making further decisions in the businesses. The study estimates the factors that are driving or hampering the growth of the industries.

Interested in Purchasing this Report? Click here @
https://www.theinsightpartners.com/buy/TIPHE100000853/?source=openpr-10411

The report highlights the risks and challenging factors which has been faced by different stakeholders and new entrants in the Genome Editing Market. Additionally, it offers a closer and analytical look at numerous companies that strive for the highest market shares. The report also elaborates on the global opportunities and ways to enlarge the businesses globally. It presents the scope of this Global Market in the developing and developed regions. It also covers how the concept of this Genome Editing Market is giving new opportunities for increasing global customers rapidly. This informative report further makes use of graphical presentation techniques such as graphs, tables, charts and pictures.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genome Editing Market Thriving Revenue of US$ 10,691.0 million by 2025 with Leading Vendors: Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., GenScript, Horizon Discovery Group plc, Sangamo Therapeutics, Inc. here

News-ID: 2303068 • Views: 196

More Releases from The Insight Partners

New Technology Developments in Active grill shutter Market to Grow during Foreca …
The Active grill shutter Market report provides a detailed overview of the industry including both qualitative and quantitative information with a special focus on the global market trend analysis. The report aims to provide an overview of Active grill shutter market with detailed market segmentation by offering, application and geography. The global Active grill shutter market is expected to witness high growth during the forecast period. The report provides key
Automotive HUD Market Projected to Gain Significant Value by 2021-2028
The Automotive HUD Market report provides a detailed overview of the industry including both qualitative and quantitative information with a special focus on the global market trend analysis. The report aims to provide an overview of Automotive HUD market with detailed market segmentation by offering, application and geography. The global Automotive HUD market is expected to witness high growth during the forecast period. The report provides key statistics on the
Anesthesia & Respiratory Devices Market (Impact of COVID-19) Top Growing Compani …
Anesthesia & Respiratory Devices Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report. Request Exclusive Sample PDF of this Report @ https://bit.ly/3cUme2S Our expert team is consistently
Marshmallows Market: Global Industry Estimation, Regional Share and Competitor A …
Marshmallows Market 2021-2028 Global Industry research report explores analysis of historical data along with size, share, growth, demand and revenue of the global Marshmallows and estimates the future trend of market on the basis of this detailed study. The study shares market performance both in terms of volume and revenue and this factor which is useful & helpful to the business. Companies Mentioned • H.J. Heinz Company Brands LLC, Doumack

All 5 Releases


More Releases for Genome

Digital Genome Market: Growing Funding for Genomics
Genomic sequencing technology is rapidly transitioning into clinical practice, and implementation of the same into healthcare systems has been supported by substantial government investment, accounting for ~US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implement and gather evidence for broader adoption, thereby driving the market growth. The digital genome market was valued at US$ 11,065.31
Genome Editing Market Bringing In impressive Revenues
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Editing Market tremendous demand till 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. The global genome editing market can be
Genome Editing Market Growth Analysis by 2025
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Engineering Market - Global Industry Analysis 2025
Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism. Genome engineering has exhibited potential benefits in gene therapy. For instance, various genetic disorders such as Hemophilia, Myotonic dystrophy, Alzheimer’s disease, Sickle cell anemia, Gaucher disease, Cystic fibrosis (involves correction of a single gene) or asthma, autoimmune diseases, cancer, diabetes, and heart disease (involves correction of multiple genes) can be treated using genomic
Genome Engineering Market Analysis & Key Trends 2023
“To develop innovative, technologically advanced and differentiated products, the leading companies are banking on agreements with laboratories and research institutes and pouring funds into ongoing research and development projects,” says the author of the report. The global genome engineering market is anticipated to reach a valuation of US$7.21 bn by 2023 from US$2.30 bn in 2015, expanding at a remarkable CAGR of 14.2% from 2015 to 2023. Increasing Funding by Biotechnology